Abstract
Mixed lineage leukemia (MLL) (KMT2A) rearrangements (KMT2Ar) play a crucial role in leukemogenesis. Dependent on age, major differences exist regarding disease frequency, main fusion partners and prognosis. In infants, up to 80% of acute lymphoid leukemia (ALL) bear a MLL translocation and half of them are t(4;11), resulting in a poor prognosis. In contrast, in adults only 10% of acute myeloid leukemia (AML) bear t(9;11) with an intermediate prognosis. The reasons for these differences are poorly understood. Recently, we established an efficient CRISPR/Cas9-based KMT2Ar model in hematopoietic stem and progenitor cells (HSPCs) derived from human cord blood (huCB) and faithfully mimicked the underlying biology of the disease. Here, we applied this model to HSPCs from adult bone marrow (huBM) to investigate the impact of the cell of origin and fusion partner on disease development. Both genome-edited infant and adult KMT2Ar cells showed monoclonal outgrowth with an immature morphology, myelomonocytic phenotype and elevated KMT2Ar target gene expression comparable to patient cells. Strikingly, all KMT2Ar cells presented with indefinite growth potential except for MLL-AF4 huBM cells ceasing proliferation after 80 days. We uncovered ...Continue Reading
References
Apr 7, 1998·Leukemia·M R BaerC D Bloomfield
Jun 12, 2002·Lancet·Ching-Hon PuiBruce Camitta
Jan 6, 2004·International Journal of Hematology·Mariko EguchiMel Greaves
Mar 7, 2007·Molecular Cancer Therapeutics·Uma T ShankavaramJohn N Weinstein
Apr 28, 2007·Science·Frédéric BarabéJohn E Dick
Jun 10, 2008·Cancer Cell·Junping WeiJames C Mulloy
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Torsten HaferlachRobin Foà
Jul 12, 2011·Cancer Cell·Scott R DaigleRoy M Pollock
Jan 20, 2012·Bioinformatics·Jeffrey T LeekJohn D Storey
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Nov 28, 2012·Leukemia·S J HortonJ J Schuringa
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Dec 30, 2014·Blood·Yuki AokiFumihiko Ishikawa
Mar 3, 2015·Nature Genetics·Anna K AnderssonUNKNOWN St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
Apr 29, 2015·Nature Chemical Biology·Elayne Chan-PenebreKenneth W Duncan
Jul 21, 2015·Cancer Cell·Stephen H K WongMichael L Cleary
Aug 28, 2015·Blood·Corina BuecheleMichael L Cleary
Feb 26, 2016·Blood·Rebecca GardnerCameron J Turtle
Mar 18, 2016·ACS Medicinal Chemistry Letters·Kenneth W DuncanRichard Chesworth
May 30, 2017·Nature Chemical Biology·Casey L QuinlanStephan K Grant
Jul 14, 2017·Leukemia·C MeyerR Marschalek
Sep 6, 2017·British Journal of Cancer·Laure B BindelsNathalie M Delzenne
Dec 12, 2017·Nature Medicine·Hamid BolouriSoheil Meshinchi
Mar 11, 2018·International Journal of Cancer. Journal International Du Cancer·Pan PanLi-Shu Wang
Apr 14, 2018·Blood Advances·Corina SchneidawindMichael L Cleary
Sep 25, 2018·Journal of Medicinal Chemistry·Anders Højgaard HansenTrond Ulven
Aug 14, 2019·Blood Advances·Theresa Okeyo-OwuorJeffrey A Magee
Aug 17, 2019·Oncogene·Kathy-Ann SeckerCorina Schneidawind
Citations
Jul 26, 2021·Experimental Hematology·Yanan Li, Jeffrey A Magee
Aug 28, 2021·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Romeo Gabriel Mihaila, Diana Topircean
Sep 8, 2021·Oncogene·Alexander Wilhelm, Rolf Marschalek